This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $37,445.14 delivery order contract is for the supply of REVLIMID 25 MG CAPSULE 21S, a pharmaceutical product. The contract has an ultimate completion date of August 27, 2024 and utilizes a Firm Fixed Price pricing type. There is no set-aside used for this award. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies to provide a wide range of essential medical commodities, including specialty medications, generic drugs, and medical supplies, to support military treatment facilities, veterans' hospitals, and other government healthcare programs nationwide.
Generated 11/5/24, 9:22 AM